Literature DB >> 19463358

Effect of septal ablation on myocardial relaxation and left atrial pressure in hypertrophic cardiomyopathy an invasive hemodynamic study.

Paul Sorajja1, Rick A Nishimura, Steve R Ommen, Charanjit S Rihal, Bernard J Gersh, David R Holmes.   

Abstract

OBJECTIVES: The objective of this study was to examine the effects of septal ablation on diastolic function with the use of invasive hemodynamics.
BACKGROUND: Septal ablation is an alternative therapy for patients with obstructive hypertrophic cardiomyopathy (HCM). However, its beneficial effect on diastolic function, by relieving the systolic contraction load, may be countered by adverse effects from the infarction on left ventricular mechanics.
METHODS: Using high-fidelity, micromanometer-tipped catheters, we examined 40 HCM patients by taking direct measurements of the left ventricular outflow tract (LVOT) gradient, time constant of myocardial relaxation (tau), and left atrial pressure (LAP) before and after septal ablation.
RESULTS: Although there was an overall reduction in LVOT gradient, septal ablation resulted in variable changes in myocardial relaxation and left atrial pressure. In 20 patients (50%), LAP increased. The magnitude of LVOT gradient reduction directly correlated with the effects of septal ablation on LAP (R = 0.58; p < 0.0001). Those patients with a greater decrease in the LVOT gradient had better improvement in direct LAP. Furthermore, those patients with a larger decrease in left ventricular outflow tract gradient had a beneficial enhancement of ventricular relaxation, as measured by tau (R = 0.43; p = 0.006). Thus, the beneficial enhancement of relaxation was directly related to improvement in LAP (R = 0.75; p < 0.0001).
CONCLUSIONS: Septal ablation results in variable effects on left ventricular filling pressure, which are dependent upon the magnitude of reduction in the LVOT gradient. These effects are mediated in part by effects of ablation on myocardial relaxation. These findings shed insight into the pathophysiologic effects of septal reduction therapy in patients with HCM.

Entities:  

Mesh:

Year:  2008        PMID: 19463358     DOI: 10.1016/j.jcin.2008.07.004

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  5 in total

1.  Does relief of outflow tract obstruction in patients with hypertrophic cardiomyopathy improve long-term survival? Implications for lowering the threshold for surgical myectomy and alcohol septal ablation.

Authors:  Srihari S Naidu; Julio A Panza; David Spielvogel; Ramin Malekan; Joshua Goldberg; Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2016-12

2.  Effects of alcohol septal ablation on left ventricular diastolic filling patterns in obstructive hypertrophic cardiomyopathy.

Authors:  You-Zhou Chen; Fu-Jian Duan; Jian-Song Yuan; Feng-Huan Hu; Jin-Gang Cui; Wei-Xian Yang; Yan Zhang; Hao Wang; Shu-Bin Qiao
Journal:  Heart Vessels       Date:  2015-03-05       Impact factor: 2.037

3.  Sex-related differences in left ventricular remodeling and outcome after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: insights from cardiovascular magnetic resonance imaging.

Authors:  You-Zhou Chen; Xing-Shan Zhao; Jian-Song Yuan; Yan Zhang; Wei Liu; Shu-Bin Qiao
Journal:  Biol Sex Differ       Date:  2022-07-07       Impact factor: 8.811

4.  Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy.

Authors:  Constantinos O'Mahony; Saidi A Mohiddin; Charles Knight
Journal:  Interv Cardiol       Date:  2014-04

5.  Impact of septal myectomy on diastolic function in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Qiulan Yang; Hao Cui; Changsheng Zhu; Haibo Hu; Jianhua Lv; Yao Liu; Yang Zhang; Hartzell V Schaff; Shuiyun Wang
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.